Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD.
paper
Cited
Public
- Authors
- Stergiakouli, Evangelia; Hamshere, Marian; Holmans, Peter; Langley, Kate; Zaharieva, Irina; deCODE Genetics; Psychiatric GWAS Consortium; Hawi, Ziarah; Kent, Lindsey; Gill, Michael; Williams, Nigel; Owen, Michael J; O'Donovan, Michael; Thapar, Anita
- Year
- 2012
- Journal
- The American journal of psychiatry
- PMID
- 22420046
- DOI
- 10.1176/appi.ajp.2011.11040551
- PMCID
- PMC3601404
OBJECTIVE: A major motivation for seeking disease-associated genetic variation is to identify novel risk processes. Although rare copy number variants (CNVs) appear to contribute to attention deficit hyperactivity disorder (ADHD), common risk variants (single-nucleotide polymorphisms [SNPs]) have not yet been detected using genome-wide association studies (GWAS). This raises the concern as to whether future larger-scale, adequately powered GWAS will be worthwhile. The authors undertook a GWAS of ADHD and examined whether associated SNPs, including those below conventional levels of significance, influenced the same biological pathways affected by CNVs. METHOD: The authors analyzed genome-wide SNP frequencies in 727 children with ADHD and 5,081 comparison subjects. The gene sets that were enriched in a pathway analysis of the GWAS data (the top 5% of SNPs) were tested for an excess of genes spanned by large, rare CNVs in the children with ADHD. RESULTS: No SNP achieved genome-wide significance levels. As previously reported in a subsample of the present study, large, rare CNVs were significantly more common in case subjects than comparison subjects. Thirteen biological pathways enriched for SNP association significantly overlapped with those enriched for rare CNVs. These included cholesterol-related and CNS development pathways. At the level of individual genes, CHRNA7, which encodes a nicotinic receptor subunit previously implicated in neuropsychiatric disorders, was affected by six large duplications in case subjects (none in comparison subjects), and SNPs in the gene had a gene-wide p value of 0.0002 for association in the GWAS. CONCLUSIONS: Both common and rare genetic variants appear to be relevant to ADHD and index-shared biological pathways.
Quantile-Quantile Plot for 502,702 Single-Nucleotide Polymorphisms (SNPs) Genotyped in 727 Case Subjects and 5,081 Comparison Subjects With Genomic Control Inflation Factor Ξ»=1.069 and Ξ»1,000=1.054 in a Study of Common Genetic Variants and ADHD Risk
Significant Overlap of Biological Pathways, Including Cholesterol-Related and CNS Development, Enriched for Single-Nucleotide Polymorphism (SNP) Association, and Those Enriched for Rare Copy Number Variants (CNVs) in a Sample of 727 Children With ADHD and 5,081 Comparison Subjects
1β20 of 34
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AngoldACostelloEJ: The Child and Adolescent Psychiatric Assessment (CAPA). J Am Acad Child Adolesc Psychiatry 2000; 39:39β481063806610.1097/00004583-200001000-00015 | β | β | β |
| AshburnerMBallCABlakeJABotsteinDButlerHCherryJMDavisAPDolinskiKDwightSSEppigJTHarrisMAHillDPIssel-TarverLKasarskisALewisSMateseJCRichardsonJERingwaldMRubinGMSherlockG: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25β291080265110.1038/75556PMC3037419 | β | β | β |
| BultCJEppigJTKadinJARichardsonJEBlakeJA: The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res 2008; 36:D724βD7281815829910.1093/nar/gkm961PMC2238849 | β | β | β |
| BurliTBaerKEwersHSidlerCFuhrerCFritschyJM: Single particle tracking of alpha7 nicotinic AChR in hippocampal neurons reveals regulated confinement at glutamatergic and GABAergic perisynaptic sites. PLoS One 2010; 5:e115072063489610.1371/journal.pone.0011507PMC2901346 | β | β | β |
| ConnersCK: Conners' Rating ScalesβRevised. New York, Multi-Health Systems, 2001 | β | β | β |
| CraddockNO'DonovanMCOwenMJ: Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Mol Psychiatry 2008; 13:649β6531850442610.1038/mp.2008.45 | β | β | β |
| EliaJGaiXXieHMPerinJCGeigerEGlessnerJTD'ArcyMDeberardinisRFrackeltonEKimCLantieriFMugangaBMWangLTakedaTRappaportEFGrantSFBerrettiniWDevotoMShaikhTHHakonarsonHWhitePS: Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010; 15:637β6461954685910.1038/mp.2009.57PMC2877197 | β | β | β |
| FaraoneSVPerlisRHDoyleAESmollerJWGoralnickJJHolmgrenMASklarP: Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:1313β13231595000410.1016/j.biopsych.2004.11.024 | β | β | β |
| FiedlerBJDebusOMNeubauerBAKienleMKurlemannG: P50 sensory gating deficit in children with centrotemporal spikes and sharp waves in the EEG. Neurosci Lett 2006; 393:206β2101624649210.1016/j.neulet.2005.09.071 | β | β | β |
| FrankeBNealeBMFaraoneSV: Genome-wide association studies in ADHD. Hum Genet 2009; 126:13β501938455410.1007/s00439-009-0663-4PMC3774416 | β | β | β |
| HolmansPGreenEKPahwaJSFerreiraMAPurcellSMSklarPOwenMJO'DonovanMCCraddockN: Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009; 85:13β241953988710.1016/j.ajhg.2009.05.011PMC2706963 | β | β | β |
| HolmesJLawsonDLangleyKFitzpatrickHTrumperAPayHHarringtonRThaparA: The Child Attention-Deficit Hyperactivity Disorder Teacher Telephone Interview (CHATTI): reliability and validity. Br J Psychiatry 2004; 184:74β781470223110.1192/bjp.184.1.74 | β | β | β |
| IngasonARujescuDCichonSSigurdssonESigmundssonTPietilainenOPBuizer-VoskampJEStrengmanEFrancksCMugliaPGylfasonAGustafssonOOlasonPISteinbergSHansenTJakobsenKDRasmussenHBGieglingIMollerHJHartmannACrombieCFraserGWalkerNLonnqvistJSuvisaariJTuulio-HenrikssonABramonEKiemeneyLAFrankeBMurrayRVassosEToulopoulouTMuhleisenTWTosatoSRuggeriMDjurovicSAndreassenOAZhangZWergeTOphoffRARietschelMNothenMMPeturssonHStefanssonHPeltonenLCollierDStefanssonKClairDM: Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry 2011; 16:17β251978696110.1038/mp.2009.101PMC3330746 | β | β | β |
| JonesLHolmansPAHamshereMLHaroldDMoskvinaVIvanovDPocklingtonAAbrahamRHollingworthPSimsRGerrishAPahwaJSJonesNStrettonAMorganARLovestoneSPowellJProitsiPLuptonMKBrayneCRubinszteinDCGillMLawlorBLynchAMorganKBrownKSPassmorePACraigDMcGuinnessBToddSHolmesCMannDSmithADLoveSKehoePGMeadSFoxNRossorMCollingeJMaierWJessenFSchurmannBvan den BusscheHHeuserIPetersOKornhuberJWiltfangJDichgansMFrolichLHampelHHullMRujescuDGoateAMKauweJSCruchagaCNowotnyPMorrisJCMayoKLivingstonGBassNJGurlingHMcQuillinAGwilliamRDeloukasPAl-ChalabiAShawCESingletonABGuerreiroRMuhleisenTWNothenMMMoebusSJockelKHKloppNWichmannHERutherECarrasquilloMMPankratzVSYounkinSGHardyJO'DonovanMCOwenMJWilliamsJ: Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010; 5:e139502108557010.1371/journal.pone.0013950PMC2981526 | β | β | β |
| KentLGreenEHolmesJThaparAGillMHawiZFitzgeraldMAshersonPCurranSMillsJPaytonACraddockN: No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder. Am J Med Genet 2001; 105:686β6891180351510.1002/ajmg.1553 | β | β | β |
| LeonardSGaultJHopkinsJLogelJVianzonRShortMDrebingCBergerRVennDSirotaPZerbeGOlincyARossRGAdlerLEFreedmanR: Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002; 59:1085β10961247012410.1001/archpsyc.59.12.1085 | β | β | β |
| LeschKPSelchSRennerTJJacobCNguyenTTHahnTRomanosMWalitzaSShoichetSDempfleAHeineMBoreatti-HummerARomanosJGross-LeschSZerlautHWultschTHeinzelSFassnachtMFallgatterAAllolioBSchaferHWarnkeAReifARopersHHUllmannR: Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 2011; 16:491β5032030899010.1038/mp.2010.29 | β | β | β |
| LeschKPTimmesfeldNRennerTJHalperinRRoserCNguyenTTCraigDWRomanosJHeineMMeyerJFreitagCWarnkeARomanosMSchaferHWalitzaSReifAStephanDAJacobC: Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 2008; 115:1573β15851883905710.1007/s00702-008-0119-3 | β | β | β |
| MickETodorovASmalleySHuXLooSToddRDBiedermanJByrneDDechairoBGuineyAMcCrackenJMcGoughJNelsonSFReiersenAMWilensTEWozniakJNealeBMFaraoneSV: Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49:898β9052073262610.1016/j.jaac.2010.02.014PMC3730251 | β | β | β |
| MiHDongQMuruganujanAGaudetPLewisSThomasPD: PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010; 38:D204βD2102001597210.1093/nar/gkp1019PMC2808919 | β | β | β |
| MillerDTShenYWeissLAKornJAnselmIBridgemohanCCoxGFDickinsonHGentileJHarrisDJHegdeVHundleyRKhwajaOKothareSLuedkeCNasirRPoduriAPrasadKRaffalliPReinhardASmithSESobeihMMSoulJSStolerJTakeokaMTanWHThakuriaJWolffRYusupovRGusellaJFDalyMJWuBL: Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009; 46:242β2481880583010.1136/jmg.2008.059907PMC4090085 | β | β | β |
| MoskvinaVHolmansPSchmidtKMCraddockN: Design of case-controls studies with unscreened controls. Ann Hum Genet 2005; 69(part 5):566β5761613891510.1111/j.1529-8817.2005.00175.x | β | β | β |
| NealeBMLasky-SuJAnneyRFrankeBZhouKMallerJBVasquezAAAshersonPChenWBanaschewskiTBuitelaarJEbsteinRGillMMirandaAOadesRDRoeyersHRothenbergerASergeantJSteinhausenHCSonuga-BarkeEMulasFTaylorELairdNLangeCDalyMFaraoneSV: Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:1337β13441898022110.1002/ajmg.b.30866PMC2831205 | β | β | β |
| NealeBMMedlandSERipkeSAshersonPFrankeBLeschKPFaraoneSVNguyenTTSchaferHHolmansPDalyMSteinhausenHCFreitagCReifARennerTJRomanosMRomanosJWalitzaSWarnkeAMeyerJPalmasonHBuitelaarJVasquezAALambregts-RommelseNGillMAnneyRJLangelyKO'DonovanMWilliamsNOwenMThaparAKentLSergeantJRoeyersHMickEBiedermanJDoyleASmalleySLooSHakonarsonHEliaJTodorovAMirandaAMulasFEbsteinRPRothenbergerABanaschewskiTOadesRDSonuga-BarkeEMcGoughJNisenbaumLMiddletonFHuXNelsonS: Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49:884β8972073262510.1016/j.jaac.2010.06.008PMC2928252 | β | β | β |
| NealeBMMedlandSRipkeSAnneyRJAshersonPBuitelaarJFrankeBGillMKentLHolmansPMiddletonFThaparALeschKPFaraoneSVDalyMNguyenTTSchaferHSteinhausenHCReifARennerTJRomanosMRomanosJWarnkeAWalitzaSFreitagCMeyerJPalmasonHRothenbergerAHawiZSergeantJRoeyersHMickEBiedermanJ: Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49:906β9202073262710.1016/j.jaac.2010.06.007PMC2928577 | β | β | β |
| Pe'erIYelenskyRAltshulerDDalyMJ: Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 2008; 32:381β3851834820210.1002/gepi.20303 | β | β | β |
| PriceALPattersonNJPlengeRMWeinblattMEShadickNAReichD: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904β9091686216110.1038/ng1847 | β | β | β |
| Psychiatric GWAS Consortium Coordinating CommitteeCichonSCraddockNDalyMFaraoneSVGejmanPVKelsoeJLehnerTLevinsonDFMoranASklarPSullivanPF: Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009; 166:540β5561933935910.1176/appi.ajp.2008.08091354PMC3894622 | β | β | β |
| PurcellSNealeBTodd-BrownKThomasLFerreiraMABenderDMallerJSklarPde BakkerPIDalyMJShamPC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559β5751770190110.1086/519795PMC1950838 | β | β | β |
| RaychaudhuriSKornJMMcCarrollSAAltshulerDSklarPPurcellSDalyMJ: Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 2010; 6:e10010972083858710.1371/journal.pgen.1001097PMC2936523 | β | β | β |
| ShinawiMSchaafCPBhattSSXiaZPatelACheungSWLanpherBNaglSHerdingHSNevinny-StickelCImmkenLLPatelGSGermanJRBeaudetALStankiewiczP: A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 2009; 41:1269β12711989847910.1038/ng.481PMC3158565 | β | β | β |
| SimesRJ: An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 73:751β754 | β | β | β |
| StergiakouliEThaparA: Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD). Neuropsychiatr Dis Treat 2010; 6:551β5602085691810.2147/NDT.S11322PMC2938304 | β | β | β |
| SzafranskiPSchaafCPPersonREGibsonIBXiaZMahadevanSWiszniewskaJBacinoCALalaniSPotockiLKangSHPatelACheungSWProbstFJGrahamBHShinawiMBeaudetALStankiewiczP: Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010; 31:840β8502050613910.1002/humu.21284PMC3162316 | β | β | β |
| The Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661β6781755430010.1038/nature05911PMC2719288 | β | β | β |
| WangKLiMHadleyDLiuRGlessnerJGrantSFHakonarsonHBucanM: PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17:1665β16741792135410.1101/gr.6861907PMC2045149 | β | β | β |
| WangWBarrattBClaytonDToddJ: Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6:109β1181571690710.1038/nrg1522 | β | β | β |
| WechslerD: WISC-IV Administration and Scoring Manual. San Antonio, Tex, Psychological Corporation, 2003 | β | β | β |
| WilliamsNMZaharievaIMartinALangleyKMantripragadaKFossdalRStefanssonHStefanssonKMagnussonPGudmundssonOOGustafssonOHolmansPOwenMJO'DonovanMThaparA: Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010; 376:1401β14082088804010.1016/S0140-6736(10)61109-9PMC2965350 | β | β | β |
| WrayNRGoddardMEVisscherPM: Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 2007; 17:1520β1581778553210.1101/gr.6665407PMC1987352 | β | β | β |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Abnormal Association Between Neural Activity and Genetic Expressions of Impulsivity in Attention-Deficit/Hyperactivity Disorder: An Adolescent Brain Cognitive Development Study. | Jeon S et al. | β | 2025 | β |
| Genetic Etiology Link to Brain Function Underlying ADHD Symptoms and its Interaction with Sleep Disturbance: An ABCD Study. | Feng A et al. | β | 2025 | β |
| Gene - maltreatment interplay in adult ADHD symptoms: main role of a gene-environment correlation effect in a Brazilian population longitudinal study. | Tovo-Rodrigues L et al. | β | 2024 | β |
| ADHD genetic burden associates with older epigenetic age: mediating roles of education, behavioral and sociodemographic factors among older adults. | Arpawong TE et al. | β | 2023 | β |
| An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder. | da Silva BS et al. | β | 2023 | β |
| Distributed genetic effects of the corpus callosum subregions suggest links to neuropsychiatric disorders and related traits. | Campbell ML et al. | β | 2023 | β |
| Do Poor Diet and Lifestyle Behaviors Modify the Genetic Susceptibility to Impulsivity in the General Population? | Xie T et al. | β | 2023 | β |
| Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands. | Chatterjee M et al. | β | 2023 | β |
| Investigating Direct and Indirect Genetic Effects in Attention-Deficit/Hyperactivity Disorder Using Parent-Offspring Trios. | Martin J et al. | β | 2023 | β |
| Rare copy number variants in males and females with childhood attention-deficit/hyperactivity disorder. | Jung B et al. | β | 2023 | β |
| The association between polygenic risk scores for mental disorders and social cognition: A scoping review. | Fusar-Poli L et al. | β | 2023 | β |
| A phenome-wide association study of polygenic scoresΒ for attention deficit hyperactivity disorder across two genetic ancestries in electronic health record data. | Niarchou M et al. | β | 2022 | β |
| Attention/Deficit Hyperactivity Disorder in Adolescent and Young Adult Males With Fragile X Syndrome. | Klusek J et al. | β | 2022 | β |
| Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice? | Balogh L et al. | β | 2022 | β |
| Investigating the associations between irritability and hot and cool executive functioning in those with ADHD. | Colonna S et al. | β | 2022 | β |
| Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for Attention-deficit Hyperactivity Disorder. | Noori T et al. | β | 2022 | β |
| Association of Gene Variations in Ionotropic Glutamate Receptor and Attention-Deficit/Hyperactivity Disorder in the Chinese Population: A Two-Stage Case-Control Study. | Zhang Q et al. | β | 2021 | β |
| Genetic influences on externalizing psychopathology overlap with cognitive functioning and show developmental variation. | Mollon J et al. | β | 2021 | β |
| <i>COMT</i> by <i>DRD3</i> Epistatic Interaction in Modulating Behaviors in Children with ADHD: A Pharmaco-Dynamic Behavioral Approach. | Fageera W et al. | β | 2021 | β |
| Insights into attention-deficit/hyperactivity disorder from recent genetic studies. | Brikell I et al. | β | 2021 | β |
| Integrating genomics and transcriptomics: Towards deciphering ADHD. | Pujol-Gualdo N et al. | β | 2021 | β |
| Rare Recurrent Variants in Noncoding Regions Impact Attention-Deficit Hyperactivity Disorder (ADHD) Gene Networks in Children of both African American and European American Ancestry. | Liu Y et al. | β | 2021 | β |
| Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders. | Poppi LA et al. | β | 2021 | β |
| ADHD: Current Concepts and Treatments in Children and Adolescents. | Drechsler R et al. | β | 2020 | β |
| Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review. | Hollingdale J et al. | β | 2020 | β |
| Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder. | McClain L et al. | β | 2020 | β |
| Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing. | Corominas J et al. | β | 2020 | β |
| Mutations in sphingolipid metabolism genes are associated with ADHD. | Henriquez-Henriquez M et al. | β | 2020 | β |
| Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies. | Lewis AS et al. | β | 2020 | β |
| TIAM2S as a novel regulator for serotonin level enhances brain plasticity and locomotion behavior. | Chu CH et al. | β | 2020 | β |
| ADGRL3 (LPHN3) variants predict substance use disorder. | Arcos-Burgos M et al. | β | 2019 | β |
| A functional variant in SLC1A3 influences ADHD risk by disrupting a hsa-miR-3171 binding site: A two-stage association study. | Huang X et al. | β | 2019 | β |
| A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD). | Luo Y et al. | β | 2019 | β |
| Assessment of Susceptibility Risk Factors for ADHD in Imaging Genetic Studies. | Vilor-Tejedor N et al. | β | 2019 | β |
| From rare Copy Number Variations to biological processes in ADHD | Harich B et al. | β | 2019 | β |
| GWAS of Behavioral Traits. | Mehta D et al. | β | 2019 | β |
| Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development. | Freedman R et al. | β | 2019 | β |
| Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study. | Waltes R et al. | β | 2019 | β |
| Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder. | Nuzziello N et al. | β | 2019 | β |
| The role of glutamate receptors in attention-deficit/hyperactivity disorder: From physiology to disease. | Huang X et al. | β | 2019 | β |
| Zebrafish models for personalized psychiatry: Insights from individual, strain and sex differences, and modeling gene x environment interactions. | Volgin AD et al. | β | 2019 | β |
| A case-control genome-wide association study of ADHD discovers a novel association with the tenascin R (TNR) gene. | Hawi Z et al. | β | 2018 | β |
| ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity. | BΓ©langer SA et al. | β | 2018 | β |
| A new locus regulating MICALL2 expression was identified for association with executive inhibition in children with attention deficit hyperactivity disorder. | Yang L et al. | β | 2018 | β |
| Genetic Insights Into ADHD Biology. | Hayman V et al. | β | 2018 | β |
| Genetic variant for behavioral regulation factor of executive function and its possible brain mechanism in attention deficit hyperactivity disorder. | Sun X et al. | β | 2018 | β |
| Genome-Wide Analysis Reveals Four Novel Loci for Attention-Deficit Hyperactivity Disorder in Korean Youths. | Kweon K et al. | β | 2018 | β |
| Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. | Franke B et al. | β | 2018 | β |
| Recent developments in the genetics of attention-deficit hyperactivity disorder. | Grimm O et al. | β | 2018 | β |
| Association between polygenic risk scores for attention-deficit hyperactivity disorder and educational and cognitive outcomes in the general population. | Stergiakouli E et al. | β | 2017 | β |
| Attention-deficit/hyperactivity disorder associated with KChIP1 rs1541665 in Kv channels accessory proteins. | Yuan FF et al. | β | 2017 | β |
| Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. | Klein M et al. | β | 2017 | β |
| Commentary. | Kuppili PP | β | 2017 | β |
| Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder. | Poirier GL et al. | β | 2017 | β |
| Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder. | Leung PW et al. | β | 2017 | β |
| Genetic influences on ADHD symptom dimensions: Examination of a priori candidates, gene-based tests, genome-wide variation, and SNP heritability. | Bidwell LC et al. | β | 2017 | β |
| Imaging genetics in neurodevelopmental psychopathology. | Klein M et al. | β | 2017 | β |
| Long-term prenatal exposure to paracetamol is associated with DNA methylation differences in children diagnosed with ADHD. | Gervin K et al. | β | 2017 | β |
| Maternal psychopathology and offspring clinical outcome: a four-year follow-up of boys with ADHD. | Agha SS et al. | β | 2017 | β |
| Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study. | Hawi Z et al. | β | 2017 | β |
| Replicated association of Synaptotagmin (SYT1) with ADHD and its broader influence in externalizing behaviors. | Cupertino RB et al. | β | 2017 | β |
| Saikosaponin A Alleviates Symptoms of Attention Deficit Hyperactivity Disorder through Downregulation of DAT and Enhancing BDNF Expression in Spontaneous Hypertensive Rats. | Jichao S et al. | β | 2017 | β |
| Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder. | Kim DS et al. | β | 2017 | β |
| Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development. | Stergiakouli E et al. | β | 2017 | β |
| ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila. | van der Voet M et al. | β | 2016 | β |
| Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding. | Stergiakouli E et al. | β | 2016 | β |
| Decoding the non-coding genome: elucidating genetic risk outside the coding genome. | Barr CL et al. | β | 2016 | β |
| Exome chip analyses in adult attention deficit hyperactivity disorder. | Zayats T et al. | β | 2016 | β |
| Gene-set and multivariate genome-wide association analysis of oppositional defiant behavior subtypes in attention-deficit/hyperactivity disorder. | Aebi M et al. | β | 2016 | β |
| Genetics of attention-deficit/hyperactivity disorder: an update. | Akutagava-Martins GC et al. | β | 2016 | β |
| Identifying mechanisms that underlie links between COMT genotype and aggression in male adolescents with ADHD. | van Goozen SH et al. | β | 2016 | β |
| Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. | Gallo EF et al. | β | 2016 | β |
| Multivariate Imaging Genetics Study of MRI Gray Matter Volume and SNPs Reveals Biological Pathways Correlated with Brain Structural Differences in Attention Deficit Hyperactivity Disorder. | Khadka S et al. | β | 2016 | β |
| Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders. | Isles AR et al. | β | 2016 | β |
| Paternal Aging Affects Behavior in Pax6 Mutant Mice: A Gene/Environment Interaction in Understanding Neurodevelopmental Disorders. | Yoshizaki K et al. | β | 2016 | β |
| Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach. | Mooney MA et al. | β | 2016 | β |
| Psychiatric gene discoveries shape evidence on ADHD's biology. | Thapar A et al. | β | 2016 | β |
| Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD. | Tong JH et al. | β | 2016 | β |
| Testing candidate genes for attention-deficit/hyperactivity disorder in fruit flies using a high throughput assay for complex behavior. | Rohde PD et al. | β | 2016 | β |
| The dynamic epigenome and its implications for behavioral interventions: a role for epigenetics to inform disorder prevention and health promotion. | Szyf M et al. | β | 2016 | β |
| Annual research review: Rare genotypes and childhood psychopathology--uncovering diverse developmental mechanisms of ADHD risk. | Scerif G et al. | β | 2015 | β |
| Biological factors underlying sex differences in neurological disorders. | Loke H et al. | β | 2015 | β |
| Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. | SΓ‘nchez-Mora C et al. | β | 2015 | β |
| Common polygenic variation enhances risk prediction for Alzheimer's disease. | Escott-Price V et al. | β | 2015 | β |
| Converging evidence does not support GIT1 as an ADHD risk gene. | Klein M et al. | β | 2015 | β |
| Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. | SΓ‘nchez-Mora C et al. | β | 2015 | β |
| Duplications in ADHD patients harbour neurobehavioural genes that are co-expressed with genes associated with hyperactivity in the mouse. | Taylor A et al. | β | 2015 | β |
| Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications. | Szyf M | β | 2015 | β |
| Failed drug discovery in psychiatry: time for human genome-guided solutions. | Papassotiropoulos A et al. | β | 2015 | β |
| Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease. | Heck A et al. | β | 2015 | β |
| Genome-wide analysis of attention deficit hyperactivity disorder in Norway. | Zayats T et al. | β | 2015 | β |
| Modulation of aggressive behavior in mice by nicotinic receptor subtypes. | Lewis AS et al. | β | 2015 | β |
| Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder. | Martin J et al. | β | 2015 | β |
| New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. | Alemany S et al. | β | 2015 | β |
| Polygenic risk of Parkinson disease is correlated with disease age at onset. | Escott-Price V et al. | β | 2015 | β |
| Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD. | Stergiakouli E et al. | β | 2015 | β |
| Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. | Kim IH et al. | β | 2015 | β |
| The attentive brain: insights from developmental cognitive neuroscience. | Amso D et al. | β | 2015 | β |
| The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome. | Niarchou M et al. | β | 2015 | β |
| The molecular genetic architecture of attention deficit hyperactivity disorder. | Hawi Z et al. | β | 2015 | β |
| The relative contribution of common and rare genetic variants to ADHD. | Martin J et al. | β | 2015 | β |
| Advances in molecular genetic studies of attention deficit hyperactivity disorder in China. | Gao Q et al. | β | 2014 | β |
| Applying imaging genetics to ADHD: the promises and the challenges. | Wu Z et al. | β | 2014 | β |
| Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. | Martin J et al. | β | 2014 | β |
| Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity. | Heck A et al. | β | 2014 | β |
| Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. | Bolea-AlamaΓ±ac B et al. | β | 2014 | β |
| Factor structure of autistic traits in children with ADHD. | Martin J et al. | β | 2014 | β |
| Functional gene-set analysis does not support a major role for synaptic function in attention deficit/hyperactivity disorder (ADHD). | Hammerschlag AR et al. | β | 2014 | β |
| Genetic influences on alcohol use across stages of development: GABRA2 and longitudinal trajectories of drunkenness from adolescence to young adulthood. | Dick DM et al. | β | 2014 | β |
| Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population. | Martin J et al. | β | 2014 | β |
| Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. | Jarick I et al. | β | 2014 | β |
| Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. | Ramos-Quiroga JA et al. | β | 2014 | β |
| Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease. | Zhang F et al. | β | 2014 | β |
| [Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003-2006 and 2009-2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1)]. | Schlack R et al. | β | 2014 | β |
| In search of biomarkers in psychiatry: EEG-based measures of brain function. | McLoughlin G et al. | β | 2014 | β |
| Molecular genetic studies of ADHD and its candidate genes: a review. | Li Z et al. | β | 2014 | β |
| Ontogeny of inter-alpha inhibitor proteins in ovine brain and somatic tissues. | Spasova MS et al. | β | 2014 | β |
| Polygenic scores associated with educational attainment in adults predict educational achievement and ADHD symptoms in children. | de Zeeuw EL et al. | β | 2014 | β |
| Sex differences in attention Deficit Hyperactivity Disorder: candidate genetic and endocrine mechanisms. | Davies W | β | 2014 | β |
| Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. | Rovaris DL et al. | β | 2014 | β |
| Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. | Fleisher C et al. | β | 2014 | β |
| Transcription Factor Activating Protein-2Ξ² (TFAP-2Ξ²) genotype and symptoms of attention deficit hyperactivity disorder in relation to symptoms of depression in two independent samples. | Nilsson KW et al. | β | 2014 | β |
| White matter microstructure predicts autistic traits in attention-deficit/hyperactivity disorder. | Cooper M et al. | β | 2014 | β |
| Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. | Bralten J et al. | β | 2013 | β |
| Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. | Hiroi N et al. | β | 2013 | β |
| Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. | Lesch KP et al. | β | 2013 | β |
| Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. | Mavroconstanti T et al. | β | 2013 | β |
| Genetic causes of developmental disorders. | Vorstman JA et al. | β | 2013 | β |
| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. | Cross-Disorder Group of the Psychiatric Genomics Consortium et al. | β | 2013 | β |
| Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. | Akutagava-Martins GC et al. | β | 2013 | β |
| High loading of polygenic risk for ADHD in children with comorbid aggression. | Hamshere ML et al. | β | 2013 | β |
| Human genome-guided identification of memory-modulating drugs. | Papassotiropoulos A et al. | β | 2013 | β |
| Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. | Rivero O et al. | β | 2013 | β |
| Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. | Yang L et al. | β | 2013 | β |
| Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. | Hamshere ML et al. | β | 2013 | β |
| What have we learnt about the causes of ADHD? | Thapar A et al. | β | 2013 | β |
| ADHD and autism: differential diagnosis or overlapping traits? A selective review. | Taurines R et al. | β | 2012 | β |
| Attention-deficit/hyperactivity disorder genomics: update for clinicians. | Elia J et al. | β | 2012 | β |
| Genetic architectures of psychiatric disorders: the emerging picture and its implications. | Sullivan PF et al. | β | 2012 | β |
| Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. | Williams NM et al. | β | 2012 | β |
| Shared biological risks that influence brain and behaviour. | Cooper M et al. | β | 2012 | β |